Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis.

MLA

Spierings, Julia, et al. “Outcomes Linked to Eligibility for Stem Cell Transplantation Trials in Diffuse Cutaneous Systemic Sclerosis.” Rheumatology, vol. 61, no. 5, May 2022, pp. 1948–56. EBSCOhost, https://doi.org/10.1093/rheumatology/keab604.

APA

Spierings, J., Nihtyanova, S. I., Derrett-Smith, E., Clark, K. E. N., Laar, J. M. van, Ong, V., & Denton, C. P. (2022). Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis. Rheumatology, 61(5), 1948–1956. https://doi.org/10.1093/rheumatology/keab604

Chicago

Spierings, Julia, Svetlana I Nihtyanova, Emma Derrett-Smith, Kristina E N Clark, Jacob M van Laar, Voon Ong, and Christopher P Denton. 2022. “Outcomes Linked to Eligibility for Stem Cell Transplantation Trials in Diffuse Cutaneous Systemic Sclerosis.” Rheumatology 61 (5): 1948–56. doi:10.1093/rheumatology/keab604.